Skip to content

Clinical trials

Phase 3 Carcinoma, Squamous Cell trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Squamous Cell Phase: Phase 3 Country / region: Canada Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20082
20161
20172
20181
20191
20211
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated4
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer2
AVEO Pharmaceuticals, Inc.1
Ariad Pharmaceuticals1
Galera Therapeutics, Inc.1
Genzyme, a Sanofi Company1
Johnson & Johnson Enterprise Innovation Inc.1
LEO Pharma1
Merck Sharp & Dohme LLC1
Regeneron Pharmaceuticals1
University of British Columbia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Squamous Cell12
Carcinoma, Large Cell4
Carcinoma, Non-Small-Cell Lung4
Adenocarcinoma2
Carcinoma2
Keratosis, Actinic2
Neoplasm Metastasis2
Recurrence2
Squamous Cell Carcinoma of Head and Neck2
Basal Cell Carcinoma1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.